|
|
- CAS号:
- 1335210-35-9
- 英文名:
- O-Methyl Dolutegravir
- 英文别名:
- BNKY001-DL03;O-Methyl Dolutegravir;Dolutegravir O-Methyl Imp;Doultegravir O methyl impurity;Dolutegravir O-Methyl Impurity;(4r,12as)-n-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexa...;(3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-methoxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide;(4R,12aS)-N-(2,4-Difluorobenzyl)-7-Methoxy-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxaMide;(4R,12AS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide;(4R,12aS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-car boxamide
- 中文名:
- DOLUTEGRAVIR 中间体
- 中文别名:
- 多替拉韦杂质7;邻甲基度鲁特韦;多特格韦N-3;O-甲基度鲁特韦;多替拉韦中间体对照品;(4R,12AS)-N-(2,4-二氟苄基)-7-甲氧基-4-甲基-6,8-二氧代-3,4,6,8,12,12A-六氢-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3]恶嗪-9-羧酰胺;(4R,12AS)-N-((2,4-二氟苯基)甲基)-3,4,6,8,12,12A-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并(1',2':4,5)吡嗪并(2,1-B)(1,3)恶嗪-9;(4R,12AS)-N-((2,4-二氟苯基)甲基)-3,4,6,8,12,12A-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并(1',2':4,5)吡嗪并(2,1-B)(1,3)恶嗪-9-甲酰胺;(4R,12AS)-N-((2,4-二氟苯基)甲基)-3,4,6,8,12,12A-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并(1',2':4,5)吡嗪并(2,1-B)(1,3)噁嗪-9-甲酰胺;(4R,12AS)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12A-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3]恶嗪-9-甲酰胺
- CBNumber:
- CB42729257
- 分子式:
- C21H21F2N3O5
- 分子量:
- 433.41
- MOL File:
- 1335210-35-9.mol
|
|
|